Literature DB >> 28507497

Sense of coherence as a protective factor in chronic urticaria.

Alicja Ograczyk1, Joanna Miniszewska2, Anna Pietrzak1, Anna Zalewska-Janowska1.   

Abstract

INTRODUCTION: Chronic urticaria (CU) seems to be perceived as a psychodermatological disorder. Different psychological factors play an important role in CU triggering and course. One of them is a sense of coherence (SOC), which is believed to be a protective factor against anxiety and depression. AIM: To investigate quality of life (QoL) in CU patients and to compare selected psychological parameters (anxiety, depression and sense of coherence) between CU individuals and the control group.
MATERIAL AND METHODS: The study comprised 46 female patients with chronic urticaria and 33 healthy females as a control group. The following methods were employed: Urticaria Activity Score (UAS), Hospital Anxiety and Depression Scale (HADS), Sense of Coherence Questionnaire (SOC-29) and Dermatology Life Quality Index (DLQI).
RESULTS: The CU patients presented a significantly higher anxiety level in comparison to the control group (z = 4.488; p < 0.001). There were no statistically significant differences regarding depression intensity and SOC. In both groups anxiety and depression negatively correlated with global SOC and all its components. Disease severity positively correlated with QoL (ρ = 0.46, p < 0.01) and negatively with global SOC (ρ = -0.33, p < 0.05).
CONCLUSIONS: Bearing in mind higher prevalence of anxiety and depressive symptoms in our CU group, it would be useful to perform screening of these aspects in all CU patients and subsequently develop respective psychological interventions, based on enhancement of personal resources.

Entities:  

Keywords:  anxiety; chronic urticaria; depression; sense of coherence

Year:  2017        PMID: 28507497      PMCID: PMC5420610          DOI: 10.5114/ada.2017.67084

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


Introduction

Chronic urticaria (CU) affects approximately 1–4% of general population. Disease lasts more than 6 weeks and is characterized by recurrent wheals accompanied by pruritus [1, 2]. The CU is perceived as a psychodermatological condition, so psychological factors can influence hives development and exacerbation [3-6]. Additionally, the disease itself and its consequences can affect psychological well-being and worsen quality of life [7-9]. As a result patients can manifest mood disorders, anxiety and/or depression [10-13]. The prevalence of anxiety is evaluated even up to 30% [11], whereas depression accompanies approximately 17–40% of CU patients [4, 11, 13]. Although it is perceived as a difficult condition to cope with, chronic urticaria does not have to significantly impair quality of life (QoL). On the basis of Lazarus stress conception, illness is an interaction between disease demands (i.e. CU severity, clinical presentation, relapsing course, itch) and personal resources (PR) [14]. Personal resources are of a key relevance in coping with stress in daily life. They are defined as relatively stable individual features (biological, psychological, interpersonal), environmental attributes (support groups, surrounding characteristics) and their mutual interactions. They play an important intermediary role between stressors and coping strategies applied. As a result, a human being can fulfill his needs and achieve his aims effectively [14-16]. A sense of coherence is believed to be one of the PRs [14]. Sense of coherence (SOC) is defined as a generalized way of world perception (taking into account cognitive and emotional aspects), which allows to notice incoming stimuli (internal and external) as understandable, under control and meaningful [14, 17]. Sense of coherence comprises 3 components: comprehensibility (incoming stimuli are perceived as coherent and structured; as a result a person can understand, explain and predict phenomena), manageability (the element responsible for assessment of resources; abilities to cope with demands related to incoming stimuli; due to them an individual does not feel helpless when facing difficulties) and meaningfulness (the belief that it is worth engaging in life challenges and investing energy in them; a human being is convinced that his actions have sense) [14, 17–19]. Individuals with strong SOC assess less life events as dangerous, apply active coping strategies and they are more motivated to overcome difficulties. They are more prone to seek, achieve and use available resources, so they are more successful in their efforts than the ones with lower SOC. It was observed that SOC plays a protective role against depression and anxiety [14, 17, 18].

Aim

The aim of our study was to investigate QoL in CU patients and to compare selected psychological parameters (stress, anxiety, depression and sense of coherence) between CU individuals and the control group. The second goal was to investigate the relationships between the above variables in both studied groups.

Material and methods

The research group initially comprised 51 adults suffering from chronic urticaria (with no other dermatological conditions). Due to significant gender disproportions (only 5 males were recruited), finally, only female results (46 patients) were statistically analyzed. All the patients presented chronic inducible urticaria: dermatographic urticaria – 25 respondents (positive test with moderate stroking of the skin by wooden spatula), delayed pressure urticaria – 11 ones (positive test with suspension of weights over the shoulder for 15 min) and cold contact urticaria – 10 patients (positive test with the use of a melting ice cube held in a thin plastic bag for 5 min). Fifteen individuals indicated an important role of stress in disease exacerbation. The study included also a control group of 33 healthy females consulting dermatologists due to common warts and melanocytic nevi (individuals with any other dermatological conditions or systemic, metabolic and psychiatric disorders were excluded from the study). The participants were recruited at the Allergology Clinic of the Allergy and Asthma Diagnostic and Treatment Centre, Dermatology Clinic in the Psychodermatology Centre and Dermatology, Pediatrics Dermatology and Oncological Dermatology Clinic in Lodz. The detailed demographic characteristics of the respondents are presented in Table 1.
Table 1

Sociodemographic characteristics of the study group

ParameterCU patientsControl group
MSDRangeMSDRange
Age44.614.221–6846.314.718–78
NFractionNFraction
Educational level:
 Primary60.1310.03
 Occupational50.1180.24
 Secondary180.40130.40
 University170.36110.33
Marital status:
 Single100.2250.15
 Married250.54210.64
 Widow30.0730.09
 Divorced80.1740.12
Residence place:
 City370.80310.94
 Country90.2020.06

N – number of patients in the group, M – mean value, SD – standard deviation, CU – chronic urticaria.

Sociodemographic characteristics of the study group N – number of patients in the group, M – mean value, SD – standard deviation, CUchronic urticaria. The median disease duration (± SEM) was 11 ±10.4 months with a range of 1.5 months to 25 years. The study was approved by the Medical University of Lodz Bioethics Committee and conducted in accordance with the Helsinki Declaration. Patients gave their informed consent to participate in the research. The following methods were applied in the study: Authors’ questionnaire consisting of questions about demographic and clinical data, i.e. disease duration and severity, frequency of urticaria recurrences and exacerbation reasons. Urticaria Activity Score 7 (UAS 7) – the scale to estimate urticaria severity. The tool is recommended by the EAACI/GA2LEN/EDF guidelines. UAS was assessed as the sum of two scores (range: 0–6) – number of hives (0–3) and pruritus intensity (0–3). The disease severity was estimated over a period of 7 days, resulting in a weekly score (UAS 7) – range from 1 to 42 [20, 21]. Visual analogue scale (VAS) – the tool was used to measure itch intensity. It is a 10 cm continuum with 0 indicating no itch and 10 as the most imaginable intensity of itch (range from 0 to 10). Scores from 0 to 3 are treated as mild, 3–6 as moderate, 7–9 as severe and 10 as very severe [22]. Hospital Anxiety and Depression Scale HADS (Zigmond, Snaith, 1983) – the scale used as a screening tool for anxiety (7 items) and depression (7 items). Each statement is evaluated on a four-point scale (assessed from 0 to 3) and the results are summed up separately for two subscales; the higher the score, the more anxiety/depression symptoms the patients present. The scores from 0 to 7 are interpreted as a normal anxiety/depression level, from 8 to 10 as mild, from 11 to 15 as moderate and from 16 to 21 as severe. The result above 11 can indicate mood disorders (at present or in the past) [23, 24]. Sense of Coherence Questionnaire SOC (Antonovsky 1983, Polish adaptation by the Occupational Medicine Department, The Institute of Occupational Medicine in Lodz 1993) – the method to estimate a sense of coherence and its three components – comprehensibility, manageability, and meaningfulness. The scale consists of 29 statements, each item is evaluated on a seven-point scale. The tool allows to obtain the global result and separate scores for each of three subscales. The higher the scores, the stronger sense of coherence is observed. It is thought that healthy functioning individuals obtain about 120–130 points [17, 25, 26]. Dermatology Life Quality Index DLQI (Finlay, Khan 1994; Polish adaptation Szepietowski et al., 2004) – the scale to evaluate the dermatological patients’ QoL. It comprises 10 statements, the responses are given on a four-point scale. The higher the score, the worse QoL is. The total result equals 0 or 1, is interpreted as normal QoL. The scores of 2 and above indicate QoL impairment: namely points from 2 to 5 – slight, from 6 to 10 – moderate, between 11 to 20 – severe and from 21 to 30 – very severe [27-29].

Statistical analysis

The Statistica package (version 12) was used for statistical analysis. Mean (M), standard deviation (SD), median values (Me), standard error of measurement (SEM), percentiles (25–75%), minimum (min) and maximum (max) values are presented. Some of analyzed variables did not meet a normal distribution criterion, so non-parametric tests such as Mann-Whitney U-test (z) and Spearman’s rank correlation test (ρ) were employed. The statistical significance level was set at p < 0.05.

Results

Disease characteristics and psychological measures

The median UAS 7 score was 35 (range: 7–42; SEM = 1.40). The median VAS itch result was 3 (range: 0.1–10; SEM = 2.17), which can be interpreted as pruritus of moderate intensity. Disease severity positively correlated with itch intensity (ρ = 0.34, p < 0.05) and QoL (ρ = 0.46, p < 0.01) and negatively with a global sense of coherence (ρ = –0.33, p < 0.05). Itch intensity was positively associated with QoL (ρ = 0.51, p < 0.001). The relationships between age, disease duration and psychological parameters were not observed (p > 0.05).

Quality of life in CU patients

Analyzing the results regarding QoL, 12 urticaria patients evaluated it as normal, and 34 noticed disease influence on their functioning. Fifteen respondents assessed impairment as slight, 10 as moderate, 8 as severe and 1 as very severe. The statistically significant correlations between QoL and anxiety, depression were not noted (p > 0.05).

Anxiety, depression and sense of coherence in studied groups

First of all, CU patients presented a significantly higher anxiety level (z = 4.488; p < 0.001) in comparison to the control group (Figure 1). However, we did not observe any statistically significant differences between groups regarding depressive symptoms (p > 0.05). Detailed evaluation of anxiety and depression intensity is presented in Table 2.
Figure 1

Comparison of anxiety intensity in CU patients and control group

Me, 25%-75% percentiles (box), min and max values are presented.

Table 2

The assessment of anxiety and depression intensity in the chronic urticaria (CU) patients group and in the control group

VariableCU patientsControl group
NFractionNFraction
Anxiety intensity:
 Normal250.54270.82
 Mild90.2050.15
 Moderate70.1500.00
 Severe50.1110.03
Depression intensity:
 Normal360.78280.85
 Mild100.2240.12
 Moderate40.0810.03
 Severe10.0200.00

N – number of people in a group.

Comparison of anxiety intensity in CU patients and control group Me, 25%-75% percentiles (box), min and max values are presented. The assessment of anxiety and depression intensity in the chronic urticaria (CU) patients group and in the control group N – number of people in a group. Secondly, comparing a sense of coherence and its components, no statistically significant results were found between the studied groups (p > 0.05). But, it is worth underlying that CU patients obtained high results regarding global SOC and mean scores in three subscales (total: 141.6 ±27.6 (mean ± SD); comprehensibility: 48.1 ±12.4, manageability: 50.1 ±10.9 and meaningfulness: 43.4 ±7.7). Finally, a sense of coherence and its components negatively correlated with anxiety and depression intensity in both groups. In CU patients correlation coefficients were higher. Of note, relations between manageability and anxiety, and total SOC and anxiety presented the strongest associations in our study (Table 3), underlying an opposite SOC role to symptoms of mood disorders.
Table 3

Correlations between sense of coherence and anxiety and depression in the chronic urticaria (CU) patients group and in the control group

Correlations betweenCU patientsControls
ρpρp
Comprehensibilityand anxiety–0.49< 0.001–0.36< 0.01
Manageability–0.65< 0.001–0.51< 0.001
Meaningfulness–0.45< 0.001–0.44< 0.001
Sense of coherence (total)–0.62< 0.001–0.48< 0.001
Comprehensibilityand depression–0.39< 0.01–0.36< 0.01
Manageability–0.61< 0.001–0.53< 0.001
Meaningfulness–0.48< 0.001–0.40< 0.001
Sense of coherence (total)–0.58< 0.001–0.49< 0.001

ρ - Spearman's rank correlation coefficient, p - significance level.

Correlations between sense of coherence and anxiety and depression in the chronic urticaria (CU) patients group and in the control group ρ - Spearman's rank correlation coefficient, p - significance level.

Discussion

We showed a substantial impairment of QoL in 34 patients. Eight of them estimated it as severe and 1 as very severe. The worse QoL in the CU group was observed by many researchers [30-34]. We noted that disease severity and pruritus intensity positively correlated with QoL. Thus, it could be directly associated with CU specific as chronic course, the lesions on exposed parts of the body, together with difficulties in controlling symptoms [11, 13, 35]. Other studies also revealed similar relations between CU severity, itch and QoL [7, 32–35]. Moreover, we also observed statistically significant differences between CU patients and the control group. They concerned an anxiety level, which was higher in individuals suffering from urticaria. This result is consistent with other studies presenting enhanced anxiety symptoms in CU patients [11, 13, 36–39]. Taking into consideration that almost one third of the CU group reported stress (which is usually experienced as fear [40]) as a causative factor, we could consider a specific vicious cycle formulation. Namely, experiencing a stressful situation can lead to disease development and exacerbation, and on the other hand, it could be an illness consequence [6, 11, 13]. There were no differences between study groups regarding the depression level. However, taking into account the scale interpretation, it appeared that 15 people reported depressive symptoms (10 individuals evaluated them as mild, 4 as severe and 1 as very severe). Studies of the other researchers [4, 11, 13, 37–39] confirmed a higher depression level in CU patients. Moreover, recent literature data indicate that adolescents who suffer from non-infectious urticaria are at a higher risk of developing major depression [41]. Weller et al. [42] demonstrated that different CU types could be associated with anxiety and depressive symptoms, which seemed to be less frequently encountered in patients with autoreactive chronic spontaneous urticaria. Despite a simple lack of differences in the sense of coherence between CU patients and controls (p > 0.05), the interpretation of the obtained results seems to be of a key relevance. While referring the scores of the CU group to norms published in the literature [17, 43], they were in the range of high results (general score) and average ones concerning three SOC components. It can be a confirmation of an important role of SOC as a personal resource in coping with stress and discomfort related to disease [44] (bearing in mind a negative correlation between SOC and disease severity). The stronger SOC, the better possibilities to adjust to illness [26]. In other studies with dermatological patients suffering from psoriasis, rosacea and CU [13, 25, 45], the decrease in the sense of coherence was not noted either. On the contrary, a lower SOC was observed in other groups, such as in patients with epilepsy, chronic renal failure, asthma and depression, which are perceived as more life-threatening conditions than skin diseases, generally regarded as less dangerous [25, 46, 47]. The protective role of SOC was also confirmed regarding its negative relationships with depression and anxiety levels. Similar correlations were observed by other authors [13, 43, 48, 49]. Moreover, it was proved that the sense of coherence can be enhanced as a result of patients’ education during climate therapy in psoriatics [50]. It could be worth investigating SOC improvement by the employment of the psychological intervention in urticaria patients. As for study limitations, we employed DLQI to assess QoL in CU patients. Inevitably, a more specific tool such as the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) [32] would generate more concrete data.

Conclusions

Taking into account the prevalence of mood disorders in the CU group, it would be useful to employ this aspect in screening in order to provide holistic professional care to patients. The SOC appeared to be a protective factor against anxiety and depression, so it is worth applying psychological interventions, enhancing personal resources, in a therapeutic plan for chronic urticaria individuals. It seems that holistic treatment provided by an interdisciplinary team of specialists from different fields, i.e. a dermatologist, allergologist, psychiatrist, psychologist, and psychotherapist could deliver the best cost-effective therapy to CU patients.
  35 in total

Review 1.  Antonovsky's sense of coherence scale and the relation with health: a systematic review.

Authors:  Monica Eriksson; Bengt Lindström
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

2.  The hospital anxiety and depression scale.

Authors:  R P Snaith; A S Zigmond
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

3.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

4.  [Sense of coherence in persons suffering from psoriasis].

Authors:  Ewa Ogłodek; Beata Augustyńska; Luiza Marek; Aleksander Araszkiewicz; Waldemar Placek; Danuta Mós
Journal:  Pol Merkur Lekarski       Date:  2009-09

5.  Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria.

Authors:  Mine Ozkan; Serap Batmaz Oflaz; Nazmiye Kocaman; Ferhan Ozseker; Ash Gelincik; Suna Büyüköztürk; Sedat Ozkan; Bahattin Colakoğlu
Journal:  Ann Allergy Asthma Immunol       Date:  2007-07       Impact factor: 6.347

6.  Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress.

Authors:  Zenon Brzoza; Alicja Kasperska-Zajac; Karina Badura-Brzoza; Jerzy Matysiakiewicz; Robert T Hese; Barbara Rogala
Journal:  Psychosom Med       Date:  2008-07       Impact factor: 4.312

7.  Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria.

Authors:  M Hashiro; M Okumura
Journal:  J Dermatol Sci       Date:  1994-10       Impact factor: 4.563

8.  Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria.

Authors:  Faruk Uguz; Burhan Engin; Ertan Yilmaz
Journal:  J Psychosom Res       Date:  2008-02       Impact factor: 3.006

Review 9.  Assessment of severity and quality of life in chronic urticaria.

Authors:  I Jáuregui; F J Ortiz de Frutos; M Ferrer; A Giménez-Arnau; J Sastre; J Bartra; M Labrador; J F Silvestre; A Valero
Journal:  J Investig Allergol Clin Immunol       Date:  2014       Impact factor: 4.333

10.  Increased risk of major depression subsequent to a first-attack and non-infection caused urticaria in adolescence: a nationwide population-based study.

Authors:  Chia-Lun Kuo; Chi-Yen Chen; Hui-Ling Huang; Wen-Liang Chen; Hua-Chin Lee; Chih-Yu Chang; Chu-Chung Chou; Shinn-Ying Ho; Han-Ping Wu; Yan-Ren Lin
Journal:  BMC Pediatr       Date:  2014-07-11       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.